no more compounding glp 1 drugs Managing Compounded GLP-1 Medications: A Pharmacist's Guide for Employers – Sequoia Despite FDA ruling, compounded GLP-1s
Description
Additionally, it affects a broader population, including non-diabetic individuals using these medications for weight loss
FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
CagriSema (from Novo Nordisk) combines cagrilintide and semaglutide in a single injection
When neither is ideal and alternatives are better Some patients are better served by single GLP-1 agonists like semaglutide
